Steve Norley

553 total citations
18 papers, 474 citations indexed

About

Steve Norley is a scholar working on Virology, Epidemiology and Immunology. According to data from OpenAlex, Steve Norley has authored 18 papers receiving a total of 474 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Virology, 8 papers in Epidemiology and 8 papers in Immunology. Recurrent topics in Steve Norley's work include HIV Research and Treatment (14 papers), Virology and Viral Diseases (4 papers) and Cytomegalovirus and herpesvirus research (3 papers). Steve Norley is often cited by papers focused on HIV Research and Treatment (14 papers), Virology and Viral Diseases (4 papers) and Cytomegalovirus and herpesvirus research (3 papers). Steve Norley collaborates with scholars based in Germany, Netherlands and Sweden. Steve Norley's co-authors include Reinhard Kurth, Thorsten U. Vogel, Jonathan L. Heeney, Henk Niphuis, Rob Dubbes, Peter ten Haaft, Jaap Goudsmit, Brigitte Beer, Thomas F. Schulz and Wim Koornstra and has published in prestigious journals such as The Journal of Experimental Medicine, The Journal of Immunology and Journal of Virology.

In The Last Decade

Steve Norley

18 papers receiving 459 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Steve Norley Germany 12 297 174 173 145 112 18 474
J D Kluge United States 8 319 1.1× 166 1.0× 140 0.8× 100 0.7× 122 1.1× 8 474
Xiaomi Xin Japan 8 225 0.8× 62 0.4× 143 0.8× 113 0.8× 80 0.7× 11 356
William A. Lauer United States 9 227 0.8× 91 0.5× 162 0.9× 86 0.6× 86 0.8× 11 352
Susan Barnett United States 8 214 0.7× 113 0.6× 383 2.2× 88 0.6× 183 1.6× 12 545
Mike M. Pütz United Kingdom 10 269 0.9× 246 1.4× 184 1.1× 40 0.3× 193 1.7× 10 454
S. Nordlund Sweden 6 198 0.7× 135 0.8× 282 1.6× 113 0.8× 184 1.6× 6 442
Judith Ahlers United States 7 222 0.7× 131 0.8× 356 2.1× 55 0.4× 106 0.9× 7 474
Vanessa B. Soros United States 9 394 1.3× 201 1.2× 176 1.0× 196 1.4× 300 2.7× 13 660
Walter E. Demkowicz United States 7 349 1.2× 221 1.3× 291 1.7× 67 0.5× 246 2.2× 7 557
Kurt Bieler Germany 10 323 1.1× 114 0.7× 168 1.0× 128 0.9× 219 2.0× 11 479

Countries citing papers authored by Steve Norley

Since Specialization
Citations

This map shows the geographic impact of Steve Norley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steve Norley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steve Norley more than expected).

Fields of papers citing papers by Steve Norley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steve Norley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steve Norley. The network helps show where Steve Norley may publish in the future.

Co-authorship network of co-authors of Steve Norley

This figure shows the co-authorship network connecting the top 25 collaborators of Steve Norley. A scholar is included among the top collaborators of Steve Norley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steve Norley. Steve Norley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Höhn, Oliver, Duc Vu, Gerd Baldenhofer, et al.. (2012). CCL19 as an adjuvant for intradermal gene gun immunization in a Her2/neu mouse tumor model: improved vaccine efficacy and a role for B cells as APC. Cancer Gene Therapy. 19(12). 880–887. 26 indexed citations
2.
Ferguson, David, A.M. Wade-Evans, P. Silvera, et al.. (2007). Preparation and characterization of new challenge stocks of SIVmac32H J5 following rapid serial passage of virus in vivo. Journal of Medical Primatology. 36(3). 131–142. 6 indexed citations
3.
Kuate, Seraphin, Christiane Stahl‐Hennig, Heribert Stoiber, et al.. (2006). Immunogenicity and efficacy of immunodeficiency virus-like particles pseudotyped with the G protein of vesicular stomatitis virus. Virology. 351(1). 133–144. 40 indexed citations
4.
Koopman, Gerrit, Daniëlla Mortier, Sam Hofman, et al.. (2004). Vaccine protection from CD4+ T-cell loss caused by simian immunodeficiency virus (SIV) mac251 is afforded by sequential immunization with three unrelated vaccine vectors encoding multiple SIV antigens. Journal of General Virology. 85(10). 2915–2924. 31 indexed citations
5.
Baier, Michael, Steve Norley, Julia Schultz, et al.. (2003). Prion diseases: infectious and lethal doses following oral challenge. Journal of General Virology. 84(7). 1927–1929. 23 indexed citations
6.
Greensill, Julie, Julie Sheldon, Neil Renwick, et al.. (2000). Two Distinct Gamma-2 Herpesviruses in African Green Monkeys: a Second Gamma-2 Herpesvirus Lineage among Old World Primates?. Journal of Virology. 74(3). 1572–1577. 59 indexed citations
7.
Norley, Steve. (1999). Why are the natural hosts of SIV resistant to AIDS?. Immunology Letters. 66(1-3). 47–52. 18 indexed citations
8.
Baier, Michael, Norbert Bannert, Albrecht Werner, et al.. (1998). Chemoattractant Factors and the Control of Human Immunodeficiency Virus Replication. Pathobiology. 66(3-4). 128–130. 3 indexed citations
9.
Bogers, Willy, Jaap Goudsmit, Babs E. Verstrepen, et al.. (1998). Characteristics of primary infection of a European human immunodeficiency virus type 1 clade B isolate in chimpanzees.. Journal of General Virology. 79(12). 2895–2903. 27 indexed citations
10.
Cranage, Martin, Natasha Polyanskaya, Steve Norley, et al.. (1998). In vivo resistance to simian immunodeficiency virus superinfection depends on attenuated virus dose.. Journal of General Virology. 79(8). 1935–1944. 20 indexed citations
11.
Norley, Steve, et al.. (1996). Induction of antibodies against SIV antigens after intramuscular nucleic acid inoculation using complex expression constructs. Journal of Biotechnology. 44(1-3). 59–65. 8 indexed citations
12.
Vries, Petra de, Jonathan L. Heeney, Jolande Boes, et al.. (1994). Protection of rhesus macaques from SIV infection by immunization with different experimental SIV vaccines. Vaccine. 12(15). 1443–1452. 23 indexed citations
13.
Heeney, Jonathan L., Cécile A. C. M. van, Petra de Vries, et al.. (1994). Major histocompatibility complex class I-associated vaccine protection from simian immunodeficiency virus-infected peripheral blood cells.. The Journal of Experimental Medicine. 180(2). 769–774. 65 indexed citations
14.
Vogel, Thorsten U., Reinhard Kurth, & Steve Norley. (1994). The majority of neutralizing Abs in HIV-1-infected patients recognize linear V3 loop sequences. Studies using HIV-1MN multiple antigenic peptides.. The Journal of Immunology. 153(4). 1895–1904. 77 indexed citations
15.
Heeney, Jonathan L., Lennart Holterman, Peter ten Haaft, et al.. (1994). Vaccine protection and reduced virus load from heterologous macaque-propagated SIV challenge.. PubMed. 10 Suppl 2. S117–21. 33 indexed citations
16.
Cichutek, Klaus, et al.. (1993). Self-Limiting Infection by int/nef-Double Mutants of Simian Immunodeficiency Virus. Virology. 193(1). 115–123. 10 indexed citations
17.
Norley, Steve & Reinhard Kurth. (1991). Neutralizing Antibodies and Antigens. 3 indexed citations
18.
Kurth, R., et al.. (1991). Epidemiology and pathogenicity of human retroviruses.. PubMed. 75. 105–11. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026